Protocol
SJBC3: Mature B-Cell Lymphoma and Leukemia Study III
Diseases
Leukemias / Lymphomas : Leukemia and lymphoma
Description
This study details about Non-Hodgkin’s Lymphoma called mature B-Cell lymphoma. Non-Hodgkin’s Lymphoma is a cancer of the lymph nodes (lymph nodes are tissues throughout the body that filter disease germs from the blood). Many children and young adults with mature B-cell lymphoma can be cured with current standard treatments, but these standard treatments do not stop every child’s cancer from coming back. Furthermore, many children have significant side effects from treatment, both at the time of treatment and for many years after treatment is completed (late effects).
Objectives
- Learn more about the biology and genetics of this disease in children in the U.S. and at several international sites.
- Study the effects (good and bad) of this treatment in St. Jude participants in order to help researchers guide treatment for children and young adults with this disease in the future.
Eligibility
- Patient must have a histologic diagnosis of a mature B cell lymphoma
- Patient must be less than 22 years of age at the time of diagnosis
- Patients known to be HIV positive are eligible for biology studies only
- Pregnant or lactating will not be eligible for the study
For the current eligibility status of this clinical study, referring physicians must contact St. Jude Children's Research Hospital at 1-866-2ST-JUDE (1-866-278-5833).
Contact
John Sandlund, MD
St. Jude Children’s Research Hospital
262 Danny Thomas Place
Memphis, TN 38105 USA
Voice: 1-866-2ST-JUDE (1-866-278-5833)
FAX: 901-595-5068
Referring or consulting physicians only: protocolinfo@stjude.org
For all other inquiries about St. Jude Children's Research Hospital studies: info@stjude.org
The above information is intended to provide only a basic description about a research protocol that may be currently active at St. Jude. The details made available here may not be the most up-to-date information on protocols used by St. Jude. To receive full details about a protocol and its status and or use at St. Jude, a physician must contact St. Jude directly.